Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04796012 |
|---|---|
| Brief Title: | VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors |
| First Submitted : | February 22, 2021 |
| First Submitted that Met QC Criteria : | March 9, 2021 |
| First Posted : | March 12, 2021 |
| Last Update Submitted that Met QC Criteria : | May 14, 2024 |
| Last Update Posted : | May 16, 2024 |